Why the study?
Does early administration of beta-blockers reduce in-hospital mortality in adults with acute or suspected MI?
Does early administration of beta-blockers reduce in-hospital mortality in adults with acute or suspected MI?
Early administration of beta-blockers in patients with acute or suspected MI does not significantly improve in-hospital mortality and may increase the risk of cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Early beta-blockers do not reduce in-hospital mortality in acute MI; confirms neutral effect on primary endpoint and supports caution for shock risk.
OBJECTIVES: Beta-blockade is currently recommended in the early management of patients with acute coronary syndromes (ACS). This was a systematic review of the medical literature to determine if early beta-blockade improves the outcome of patients with ACS. METHODS: The authors searched the PubMed and EMBASE databases for randomized controlled trials from 1965 through May 2009 using a search strategy derived from the following PICO formulation of our clinical question: Patients included adults (18+ years) with an acute or suspected myocardial infarction (MI) within 24 hours of onset of chest pain. Intervention included intravenous or oral beta-blockers administered within 8 hours of presentation. The comparator included standard medical therapy with or without placebo versus early beta-blocker administration. The outcome was the risk of in-hospital death in the intervention groups versus the comparator groups. The methodologic quality of the studies was assessed. Qualitative methods were used to summarize the study results. In-hospital mortality rates were compared using a forest plot of relative risk (RR; 95% confidence interval [CI]) between beta-blockers and controls. Statistical analysis was done with Review Manager V5.0. RESULTS: Eighteen articles (total N = 72,249) met the inclusion/exclusion criteria. For in-hospital mortality, RR = 0.95 (95% CI, 0.90-1.01). In the largest of these studies (n = 45,852), a significantly higher rate (p < 0.0001) of cardiogenic shock was observed in the beta-blocker (5.0%) versus control group (3.9%). CONCLUSIONS: This systematic review failed to demonstrate a convincing in-hospital mortality benefit for using beta-blockers early in the course of patients with an acute or suspected MI.
No takes yet. Share an insight, caveat, or question.
Brandler et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: